{"pmid":32445630,"title":"Vitamin-D and COVID-19: do deficient risk a poorer outcome?","text":["Vitamin-D and COVID-19: do deficient risk a poorer outcome?","Lancet Diabetes Endocrinol","Mitchell, Fiona","32445630"],"journal":"Lancet Diabetes Endocrinol","authors":["Mitchell, Fiona"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445630","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/S2213-8587(20)30183-2","topics":["Treatment"],"weight":1,"_version_":1667600475819606017,"score":9.490897,"similar":[{"pmid":32503801,"title":"Does vitamin D deficiency increase the severity of COVID-19?","text":["Does vitamin D deficiency increase the severity of COVID-19?","The severity of coronavirus 2019 infection (COVID-19) is determined by the presence of pneumonia, severe acute respiratory distress syndrome (SARS-CoV-2), myocarditis, microvascular thrombosis and/or cytokine storms, all of which involve underlying inflammation. A principal defence against uncontrolled inflammation, and against viral infection in general, is provided by T regulatory lymphocytes (Tregs). Treg levels have been reported to be low in many COVID-19 patients and can be increased by vitamin D supplementation. Low vitamin D levels have been associated with an increase in inflammatory cytokines and a significantly increased risk of pneumonia and viral upper respiratory tract infections. Vitamin D deficiency is associated with an increase in thrombotic episodes, which are frequently observed in COVID-19. Vitamin D deficiency has been found to occur more frequently in patients with obesity and diabetes. These conditions are reported to carry a higher mortality in COVID-19. If vitamin D does in fact reduce the severity of COVID-19 in regard to pneumonia/ARDS, inflammation, inflammatory cytokines and thrombosis, it is our opinion that supplements would offer a relatively easy option to decrease the impact of the pandemic.","Clin Med (Lond)","Weir, E Kenneth","Thenappan, Thenappan","Bhargava, Maneesh","Chen, Yingjie","32503801"],"abstract":["The severity of coronavirus 2019 infection (COVID-19) is determined by the presence of pneumonia, severe acute respiratory distress syndrome (SARS-CoV-2), myocarditis, microvascular thrombosis and/or cytokine storms, all of which involve underlying inflammation. A principal defence against uncontrolled inflammation, and against viral infection in general, is provided by T regulatory lymphocytes (Tregs). Treg levels have been reported to be low in many COVID-19 patients and can be increased by vitamin D supplementation. Low vitamin D levels have been associated with an increase in inflammatory cytokines and a significantly increased risk of pneumonia and viral upper respiratory tract infections. Vitamin D deficiency is associated with an increase in thrombotic episodes, which are frequently observed in COVID-19. Vitamin D deficiency has been found to occur more frequently in patients with obesity and diabetes. These conditions are reported to carry a higher mortality in COVID-19. If vitamin D does in fact reduce the severity of COVID-19 in regard to pneumonia/ARDS, inflammation, inflammatory cytokines and thrombosis, it is our opinion that supplements would offer a relatively easy option to decrease the impact of the pandemic."],"journal":"Clin Med (Lond)","authors":["Weir, E Kenneth","Thenappan, Thenappan","Bhargava, Maneesh","Chen, Yingjie"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32503801","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.7861/clinmed.2020-0301","keywords":["covid 19","treg","vitamin d","coronavirus","inflammation"],"e_drugs":["Vitamin D"],"topics":["Treatment"],"weight":1,"_version_":1668892488253833216,"score":51.461937},{"pmid":32474141,"title":"Vitamin D deficiency and COVID-19 pandemic.","text":["Vitamin D deficiency and COVID-19 pandemic.","J Glob Antimicrob Resist","Zemb, Patrick","Bergman, Peter","Camargo, Carlos A Jr","Cavalier, Etienne","Cormier, Catherine","Courbebaisse, Marie","Hollis, Bruce","Minisola, Salvatore","Pilz, Stefan","Pludowski, Pawel","Schmitt, Francois","Zdrenghea, Mihnea","Souberbielle, Jean-Claude","32474141"],"journal":"J Glob Antimicrob Resist","authors":["Zemb, Patrick","Bergman, Peter","Camargo, Carlos A Jr","Cavalier, Etienne","Cormier, Catherine","Courbebaisse, Marie","Hollis, Bruce","Minisola, Salvatore","Pilz, Stefan","Pludowski, Pawel","Schmitt, Francois","Zdrenghea, Mihnea","Souberbielle, Jean-Claude"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474141","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.jgar.2020.05.006","topics":["Prevention"],"weight":1,"_version_":1668341932716195840,"score":48.69169},{"pmid":32476189,"title":"SARS-CoV-2 pandemic and Vitamin D deficiency - a double trouble.","text":["SARS-CoV-2 pandemic and Vitamin D deficiency - a double trouble.","The current SARS-CoV-2 pandemic has mandated significant isolation measures. Streets in affected countries are mostly empty, and many individuals spend several consecutive days at home to reduce the risk of infection. While determinant for pandemic control, home reclusion may have a significant toll on the health of individuals.","Photodermatol Photoimmunol Photomed","Alpalhao, Miguel","Filipe, Paulo","32476189"],"abstract":["The current SARS-CoV-2 pandemic has mandated significant isolation measures. Streets in affected countries are mostly empty, and many individuals spend several consecutive days at home to reduce the risk of infection. While determinant for pandemic control, home reclusion may have a significant toll on the health of individuals."],"journal":"Photodermatol Photoimmunol Photomed","authors":["Alpalhao, Miguel","Filipe, Paulo"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32476189","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/phpp.12579","keywords":["sars-cov-2","isolation","pandemic","vitamin d"],"locations":["Vitamin"],"topics":["Prevention"],"weight":1,"_version_":1668437835013685248,"score":41.168053}]}